First Vaginal Mesh Cases Set for Trial

If you are one of the many women who have received a mesh implant to deal with organ prolapse, or urinary incontinence, and are experiencing significant complications, then you should know that litigation against the companies that made and distributed these devices is proceeding.  We are representing dozens of clients suffering from failed mesh devices, and are happy to report that on May 1, 2011, U.S. District Court Judge Joseph R. Goodwin picked a trial date for the first 600 pelvic mesh cases against C.R. Bard. Plaintiffs allege that Bard’s AVAULTA device caused organ damage, among other “devistating consequences.”  Hundreds of civil actions against Bard have been consolidated in Multi-District Litigation (MDL 2187) in Charleston, West Virginia.  The Bard MDL is one of four MDLs involving other manufacturers’ defective products, including: Johnson & Johnson’s Ethicon division (MDL 2327); American Medical Systems (MDL 2325), and Boston Scientific (MDL 2326). C.R. Bard and J&J”s Ethicon division are also facing mass-tort litigation in the state courts of New Jersey, where they are headquartered.  More than 75,000 women each year have devices inserted in an attempt to support organs that are pushing, or bulging, out of place (known as organ prolapse), or for urinary incontinence.  We will keep you updated on these MDLs as they progress.

Leave a Comment

You must be logged in to post a comment.